Olanzapine Glenmark

Medicinal product

(Invented) name

Olanzapine Glenmark

Active substance (s)

Olanzapinas

Strength

15 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH03, Olanzapine

Marketing authorisation holder

Glenmark Arzneimittel GmbH, Vokietija

Date of authorisation

2009-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Olanzapinas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
38826	52508	1052508	lizdinė plokštelė	N28		Receptinis	EU/1/09/587/013	Netiekiama	-	-	No	-	-
38827	52509	1052509	lizdinė plokštelė	N56		Receptinis	EU/1/09/587/014	Netiekiama	-	-	No	-	-
38828	52510	1052510	lizdinė plokštelė	N70		Receptinis	EU/1/09/587/015	Netiekiama	-	-	No	-	-
100861	86972	1086972	lizdinė plokštelė	N98		Receptinis	EU/1/09/587/024	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-12-03	Registruotas